More about Coromandel International Limited
Fundamentals for Coromandel International Limited
Regulatory Filings for Coromandel International Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Coromandel International Limited
Business Operations:
Sector: Basic MaterialsIndustry: Agricultural Inputs
Coromandel International Limited provides agriculture solutions in India and internationally. It operates through Nutrient and Other Allied Business, and Crop Protection segments. The company's crop nutrients comprises fertilizer, which includes complex, urea, potash muriate, Di-ammonium phosphate, and single superphosphate; specialty nutrients, such as crop specific water and generic water soluble grades, Sulphur based fertilizers, and micronutrients; and organic fertilizers. It also offers crop protection products including insecticide, herbicide, fungicide, bio-products, and plant growth regulators. In addition, the company operates through rural retail outlets, which provides soil testing, crop diagnostics, and farm mechanization services across Andhra Pradesh, Telangana, and Karnataka. The company was formerly known as Coromandel Fertilisers Ltd and changed its name to Coromandel International Limited in September 2009. Coromandel International Limited was incorporated in 1961 and is headquartered in Chennai, India. Coromandel International Limited is a subsidiary of E.I.D.-Parry (India) Limited.
Revenue projections:
COROMANDEL's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 21.423868 |
| debtToEquity | 11.599000 |
| earningsGrowth | -0.013000 |
| revenueGrowth | 0.266000 |
| grossMargins | 0.245500 |
| operatingMargins | 0.074390 |
| trailingEps | 81.250000 |
| forwardEps | 93.111110 |
COROMANDEL's Forward PE is in a favorable range, suggesting the stock is reasonably priced relative to its earnings. This indicates the stock is not overpriced, providing room for potential growth and making it an attractive option for investors looking for solid value and future upside.
Coromandel International Limited's Debt-to-Equity ratio is low, indicating the company is not over-leveraged. This suggests a prudent approach to financing, with minimal dependence on debt, reducing the financial risk associated with high leverage, and signaling a stable financial outlook.
COROMANDEL's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that COROMANDEL is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.
Price projections:
COROMANDEL's current valuation relative to projections shows a lack of distinct risks or opportunities. This neutral stance may lead investors to take a more conservative approach, maintaining their current positions until new information becomes available.
Insider Transactions:
1 purchases of COROMANDEL were executed, with market price of 2168.800048828125.During the period under consideration, there were no buy transactions.COROMANDEL's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.
Recommendation changes over time:
Analysts have been favoring COROMANDEL with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning COROMANDEL as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy